These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 34453222)
1. Prevention of Atherosclerotic Cardiovascular Disease in Children with Familial Hypercholesterolemia. Peterson AL; McNeal CJ; Wilson DP Curr Atheroscler Rep; 2021 Aug; 23(10):64. PubMed ID: 34453222 [TBL] [Abstract][Full Text] [Related]
2. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey. Kose E; Kose M; Ozturk SI; Ozcan E; Onay H; Ozkan B J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1251-1256. PubMed ID: 32829317 [TBL] [Abstract][Full Text] [Related]
3. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force. Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919 [TBL] [Abstract][Full Text] [Related]
4. Misperceptions and management of LDL-cholesterol in secondary prevention of patients with familial hypercholesterolemia in cardiology practice: Real-life evidence from the EPHESUS registry. Kayıkcioglu M; Başaran Ö; Doğan V; Mert KU; Mert GÖ; Özdemir İH; Rencüzoğulları İ; Karadeniz FÖ; Tekinalp M; Aşkın L; Demirelli S; Gencer E; Bekar L; Aktaş M; Resulzade MM; Kalçık M; Aksan G; Cinier G; Akay KH; Pekel N; Utku Şenol ; Demir V; İnci S; Derviş E; Özlek B; Özlek E; Çelik O; Çil C; Biteker M J Clin Lipidol; 2023; 17(6):732-742. PubMed ID: 38072583 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials). McCullough PA; Ballantyne CM; Sanganalmath SK; Langslet G; Baum SJ; Shah PK; Koren A; Mandel J; Davidson MH Am J Cardiol; 2018 Apr; 121(8):940-948. PubMed ID: 29472008 [TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolemia: Review of diagnosis, screening, and treatment. Turgeon RD; Barry AR; Pearson GJ Can Fam Physician; 2016 Jan; 62(1):32-7. PubMed ID: 26796832 [TBL] [Abstract][Full Text] [Related]
7. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia. Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300 [TBL] [Abstract][Full Text] [Related]
8. My Approach to the Patient With Familial Hypercholesterolemia. Safarova MS; Kullo IJ Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal treatment patterns among US patients with atherosclerotic cardiovascular disease or familial hypercholesterolemia initiating lipid-lowering pharmacotherapy. Burke JP; Simpson RJ; Paoli CJ; McPheeters JT; Gandra SR J Clin Lipidol; 2016; 10(6):1470-1480.e3. PubMed ID: 27919365 [TBL] [Abstract][Full Text] [Related]
10. Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents. Cohen H; Stefanutti C; Curr Atheroscler Rep; 2021 May; 23(6):30. PubMed ID: 33963467 [TBL] [Abstract][Full Text] [Related]
11. The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia. Pang J; Chan DC; Watts GF Curr Atheroscler Rep; 2020 Sep; 22(11):64. PubMed ID: 32870376 [TBL] [Abstract][Full Text] [Related]
12. The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia. Lalić K; Rajković N; Popović L; Lukač SS; Stošić L; Rasulić I; Lalić NM Atherosclerosis; 2018 Oct; 277():298-303. PubMed ID: 30270062 [TBL] [Abstract][Full Text] [Related]
13. Sex differences in the perception of cardiovascular risk in familial hypercholesterolemia. Alshibani B; Iatan I; Guerin A; Ruel I; Cermakova L; Ramanakumar AV; Pilote L; Coutinho T; Brunham LR; Genest J J Clin Lipidol; 2024; 18(1):e97-e104. PubMed ID: 37926591 [TBL] [Abstract][Full Text] [Related]
14. Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care. Balla S; Ekpo EP; Wilemon KA; Knowles JW; Rodriguez F Curr Atheroscler Rep; 2020 Aug; 22(10):60. PubMed ID: 32816232 [TBL] [Abstract][Full Text] [Related]
15. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment. Farnier M; Civeira F; Descamps O; Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482 [TBL] [Abstract][Full Text] [Related]
16. The Role of Reverse Cascade Screening in Children with Familial Hypercholesterolemia: A Literature Review and Analysis. Lokkesmoe R; Hamilton L Curr Atheroscler Rep; 2024 Aug; 26(8):427-433. PubMed ID: 38888696 [TBL] [Abstract][Full Text] [Related]
17. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk. Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017 [TBL] [Abstract][Full Text] [Related]
18. Familial hypercholesterolemia and its manifestations: Practical considerations for general practitioners. Anagnostis P; Antza C; Florentin M; Kotsis V Kardiol Pol; 2023; 81(11):1081-1088. PubMed ID: 37937357 [TBL] [Abstract][Full Text] [Related]
19. Preventing early cardiovascular death in patients with familial hypercholesterolemia. Repas TB; Tanner JR J Am Osteopath Assoc; 2014 Feb; 114(2):99-108. PubMed ID: 24481802 [TBL] [Abstract][Full Text] [Related]